Onconetix Inc (ONCO)

$0.34 -0.04 (-10.24%)
Market Cap 245,000.00
Revenue (ttm) 820,000.00
Net Income (ttm) -14.03M
EPS (ttm) N/A
PE Ratio 0.08
Forward PE N/A
Profit Margin -1,710.98%
Debt to Equity Ratio 0.00
Volume 452,842
Avg Vol 9,456,789
Day's Range N/A - N/A
Shares Out 656,000.00
Stochastic %K 6%
Beta 3.01
Analysts Strong Buy
Price Target N/A

Company Profile

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the Panc...

Industry: Biotechnology
Sector: Healthcare
Phone: 513 620 4101
Address:
201 East Fifth Street, Suite 1900, Cincinnati, United States
Dien_
Dien_ May. 18 at 4:44 PM
$ONCO all im hopoing for is the update for 19 robot deliver, but overall this company is shi
0 · Reply
bionicman1969
bionicman1969 May. 18 at 4:31 PM
$ONCO still overvalued by 33.93 cents. Strong Sell bankrupt shell with $25MM debt and preferred ahead of common. Don't see how merger ever closes. Price target . 0001
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 3:24 PM
$ONCO so much for dilution at only .67
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 3:23 PM
$ONCO get ready
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 2:51 PM
$ONCO looks like more dilution today, I thought the filing said the price had to be about.67 to dilution. But I guess as much BS as this stock pushing what does it matter
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 2:49 PM
$ONCO scam, these companies shouldn’t be able to continue this type of behavior
0 · Reply
Bikinibullshark
Bikinibullshark May. 18 at 2:23 PM
$ONCO I don’t like the stock…
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 1:41 PM
$ONCO looks like this week is the matched down to the .20s. lol
0 · Reply
JamilB91
JamilB91 May. 18 at 12:38 PM
$ONCO short this diluted pig , no revenue
0 · Reply
finansbull88
finansbull88 May. 18 at 12:29 PM
$ONCO BOOM is coming soon now
2 · Reply
Latest News on ONCO
Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

May 13, 2026, 9:25 AM EDT - 5 days ago

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

Onconetix files to sell 25M shares of common stock for holders

2026-04-28T20:18:54.000Z - 19 days ago

Onconetix files to sell 25M shares of common stock for holders

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Apr 9, 2026, 8:30 AM EDT - 5 weeks ago

Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Apr 2, 2026, 8:30 AM EDT - 6 weeks ago

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Onconetix CEO Karina Fedasz to step down, David White to succeed

2026-03-31T13:13:26.000Z - 6 weeks ago

Onconetix CEO Karina Fedasz to step down, David White to succeed

ARTW

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Mar 31, 2026, 8:30 AM EDT - 6 weeks ago

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

Mar 25, 2026, 12:47 PM EDT - 7 weeks ago

Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration

Onconetix Inc trading halted, news pending

2026-03-24T23:50:18.000Z - 7 weeks ago

Onconetix Inc trading halted, news pending

Onconetix announces 1-for-5 reverse stock split

2026-03-23T13:12:26.000Z - 2 months ago

Onconetix announces 1-for-5 reverse stock split

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Mar 23, 2026, 8:30 AM EDT - 2 months ago

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Onconetix to acquire Realbotix LLC in all-stock transaction

2026-02-12T13:27:43.000Z - 3 months ago

Onconetix to acquire Realbotix LLC in all-stock transaction

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Feb 12, 2026, 8:00 AM EST - 3 months ago

Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Feb 12, 2026, 8:00 AM EST - 3 months ago

Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer

Onconetix files to sell 22.07M shares of common stock for holders

2025-11-04T21:45:43.000Z - 6 months ago

Onconetix files to sell 22.07M shares of common stock for holders

Onconetix files to sell 5.1M shares of common stock for holders

2025-10-16T10:10:38.000Z - 7 months ago

Onconetix files to sell 5.1M shares of common stock for holders

Onconetix announces financing through private placement, debt settlement

2025-09-26T12:40:45.000Z - 8 months ago

Onconetix announces financing through private placement, debt settlement

VERU

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Sep 26, 2025, 8:30 AM EDT - 8 months ago

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Onconetix, Ocuvex announce mutual termination of merger agreement

2025-09-26T12:20:26.000Z - 8 months ago

Onconetix, Ocuvex announce mutual termination of merger agreement

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Sep 26, 2025, 8:15 AM EDT - 8 months ago

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

2025-09-22T12:10:57.000Z - 8 months ago

Onconetix’s Proteomedix licenses manufacturing IP to Immunovia

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Sep 22, 2025, 8:00 AM EDT - 8 months ago

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

Onconetix, Ocuvex execute definitive merger agreement

2025-07-16T12:21:02.000Z - 10 months ago

Onconetix, Ocuvex execute definitive merger agreement

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Jul 16, 2025, 8:17 AM EDT - 10 months ago

Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix receives positive decision by Nasdaq Hearings Panel

2025-06-16T12:25:20.000Z - 1 year ago

Onconetix receives positive decision by Nasdaq Hearings Panel

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Jun 16, 2025, 8:22 AM EDT - 1 year ago

Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel

Onconetix Inc trading halted, news pending

2025-06-12T23:50:23.000Z - 1 year ago

Onconetix Inc trading halted, news pending

Onconetix announces 1-for-85 reverse stock split

2025-06-11T15:35:06.000Z - 1 year ago

Onconetix announces 1-for-85 reverse stock split

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Jun 11, 2025, 11:30 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

Onconetix receives additional delisting notice from Nasdaq

2025-05-22T21:00:17.000Z - 1 year ago

Onconetix receives additional delisting notice from Nasdaq

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

May 22, 2025, 4:50 PM EDT - 1 year ago

Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

Onco-Innovations Uplists to Cboe Canada

May 22, 2025, 10:00 AM EDT - 1 year ago

Onco-Innovations Uplists to Cboe Canada

Biotech Alert: Searches spiking for these stocks today

2025-05-16T15:45:48.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

ADCT ALZN EXEL HUMA INM LEGN OTLK

Onconetix receives additional notice from Nasdaq

2025-04-30T22:20:21.000Z - 1 year ago

Onconetix receives additional notice from Nasdaq

Onconetix signs non-binding LOI for potential combination with Ocuvex

2025-04-08T12:42:04.000Z - 1 year ago

Onconetix signs non-binding LOI for potential combination with Ocuvex

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Mar 24, 2025, 8:45 AM EDT - 1 year ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Dec 12, 2024, 5:00 PM EST - 1 year ago

Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS VRNA GRDX

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 4:45 PM EDT - 1 year ago

Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Oct 3, 2024, 9:05 AM EDT - 1 year ago

Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Sep 20, 2024, 11:45 AM EDT - 1 year ago

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Jul 15, 2024, 6:00 AM EDT - 2 years ago

Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Jul 11, 2024, 8:17 AM EDT - 2 years ago

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Feb 13, 2024, 6:00 AM EST - 2 years ago

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Dec 19, 2023, 7:00 AM EST - 2 years ago

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Dec 18, 2023, 7:00 AM EST - 2 years ago

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Nov 2, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Nov 1, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

Blue Water Biotech Issues Letter to Shareholders

Oct 30, 2023, 7:00 AM EDT - 2 years ago

Blue Water Biotech Issues Letter to Shareholders

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Aug 28, 2023, 4:30 PM EDT - 2 years ago

Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 3, 2023, 1:02 PM EDT - 3 years ago

Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Aug 1, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Jul 31, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Jul 25, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Jul 17, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Jul 11, 2023, 9:00 AM EDT - 3 years ago

Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Jul 6, 2023, 5:05 PM EDT - 3 years ago

Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Jul 6, 2023, 7:30 AM EDT - 3 years ago

Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Jun 28, 2023, 7:55 AM EDT - 3 years ago

Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio

Jun 21, 2023, 7:30 AM EDT - 3 years ago

Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

Jun 14, 2023, 7:30 AM EDT - 3 years ago

Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas

Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights

May 12, 2023, 6:32 PM EDT - 3 years ago

Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY

May 10, 2023, 12:15 PM EDT - 3 years ago

Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY

Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer

Apr 26, 2023, 3:44 PM EDT - 3 years ago

Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer

Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®

Apr 25, 2023, 8:00 AM EDT - 3 years ago

Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®

Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company

Apr 24, 2023, 8:00 AM EDT - 3 years ago

Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company

Dien_
Dien_ May. 18 at 4:44 PM
$ONCO all im hopoing for is the update for 19 robot deliver, but overall this company is shi
0 · Reply
bionicman1969
bionicman1969 May. 18 at 4:31 PM
$ONCO still overvalued by 33.93 cents. Strong Sell bankrupt shell with $25MM debt and preferred ahead of common. Don't see how merger ever closes. Price target . 0001
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 3:24 PM
$ONCO so much for dilution at only .67
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 3:23 PM
$ONCO get ready
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 2:51 PM
$ONCO looks like more dilution today, I thought the filing said the price had to be about.67 to dilution. But I guess as much BS as this stock pushing what does it matter
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 2:49 PM
$ONCO scam, these companies shouldn’t be able to continue this type of behavior
0 · Reply
Bikinibullshark
Bikinibullshark May. 18 at 2:23 PM
$ONCO I don’t like the stock…
0 · Reply
drweinerdog1
drweinerdog1 May. 18 at 1:41 PM
$ONCO looks like this week is the matched down to the .20s. lol
0 · Reply
JamilB91
JamilB91 May. 18 at 12:38 PM
$ONCO short this diluted pig , no revenue
0 · Reply
finansbull88
finansbull88 May. 18 at 12:29 PM
$ONCO BOOM is coming soon now
2 · Reply
JamilB91
JamilB91 May. 18 at 11:19 AM
$ONCO sell sell sell
0 · Reply
Siara1620
Siara1620 May. 18 at 8:46 AM
$ONCO Garbage is reliable😆
0 · Reply
Bikinibullshark
Bikinibullshark May. 18 at 7:51 AM
$ONCO I hold 1 million myself 🤣
0 · Reply
finansbull88
finansbull88 May. 18 at 6:39 AM
$ONCO BIG news is coming Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
0 · Reply
JamilB91
JamilB91 May. 18 at 3:39 AM
$ONCO scam company , should go much lower
0 · Reply
finansbull88
finansbull88 May. 17 at 10:31 PM
$ONCO It is coming
0 · Reply
Dien_
Dien_ May. 17 at 8:32 PM
$ONCO they need to give another update on the 19 robot delevery before end of may or else it's gonna be pretty bad for their stock, might go down to 0.2 or even 0.1 if no update on 19 robot delevery
0 · Reply
nguyenmcn31
nguyenmcn31 May. 17 at 1:28 PM
$ONCO https://www.facebook.com/share/r/17shygRAuP/ China 🇨🇳 humanoid 🤖 law enforcement 👀👀👀
0 · Reply
nguyenmcn31
nguyenmcn31 May. 17 at 1:23 PM
$ONCO https://www.facebook.com/share/v/1DZJ1mMCRj/ China 🇨🇳 fighting 💪 monk, performing 🎭 on stage for the world 🌎 together see 👀 on CNN.
0 · Reply
nguyenmcn31
nguyenmcn31 May. 17 at 1:18 PM
$ONCO https://www.facebook.com/share/r/1CxDHqzHc6/ South Korea first humanoid 🤖 monks 🤖🤖🤖🙏🏾🙏🏾🙏🏾😳😳😳💰💰💰
0 · Reply
416Area
416Area May. 16 at 9:02 PM
$ONCO Float is actually 10m...updated today.
0 · Reply
JamilB91
JamilB91 May. 16 at 6:26 PM
$ONCO who is buying this turd stock identify urself now. this is a fasad company with no revenue. Sell sell sell , dilution dilution dilution , split split split
0 · Reply